Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
14.07
+0.30 (2.18%)
At close: Sep 16, 2026
SHE:301408 Revenue
Anhui Huaren Health Pharmaceutical had revenue of 1.40B CNY in the quarter ending June 30, 2026, with 13.47% growth. This brings the company's revenue in the last twelve months to 5.81B, up 19.29% year-over-year. In the year 2025, Anhui Huaren Health Pharmaceutical had annual revenue of 5.49B with 21.07% growth.
Revenue (ttm)
5.81B
Revenue Growth
+19.29%
P/S Ratio
0.97
Revenue / Employee
649.75K
Employees
8,938
Market Cap
5.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.49B | 954.99M | 21.07% |
| Dec 31, 2024 | 4.53B | 734.53M | 19.34% |
| Dec 31, 2023 | 3.80B | 534.74M | 16.39% |
| Jan 1, 2023 | 3.26B | 923.72M | 39.50% |
| Jan 1, 2022 | 2.34B | 407.79M | 21.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 27.97B |
| Yifeng Pharmacy Chain | 24.84B |
| LBX Pharmacy Chain Joint Stock Company | 22.46B |
| Luyan Pharma | 21.43B |
| Cachet Pharmaceutical | 18.10B |
| Yixintang Pharmaceutical Group | 16.89B |
| ShuYu Civilian Pharmacy Corp. | 10.76B |
| Jianzhijia Pharmaceutical Chain Group | 8.65B |